Literature DB >> 9445036

Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms.

D Schober1, P Kronenberger, E Prchla, D Blaas, R Fuchs.   

Abstract

Intercellular adhesion molecule 1 and the low-density lipoprotein receptor are used for cell entry by major and minor receptor group human rhinoviruses (HRVs), respectively. Whereas minor-group viruses, exemplified by HRV2, transfer their genomic RNA to the cytoplasm through a pore in the endosomal membrane (E. Prchla, C. Plank, E. Wagner, D. Blaas, and R. Fuchs, J. Cell Biol. 131:111-123, 1995), the mechanism of in vivo uncoating of major-group HRVs has not been elucidated so far. Using free-flow electrophoresis, we performed a comparative analysis of cell entry by HRV2 and the major group rhinovirus HRV14. Here we demonstrate that this technique allows the separation of free viral particles from those associated with early endosomes, late endosomes, and plasma membranes. Upon free-flow electrophoretic separation of microsomes, HRV14 was recovered from endosomes under conditions which prevent uncoating, whereas the proportion of free viral particles increased with time under conditions which promote uncoating. The remaining virus eluted within numerous fractions corresponding to membraneous material, with no clear endosomal peaks being discernible. This suggests that uncoating of HRV14 results in lysis of the endosomal membrane and release of subviral 135S and 80S particles into the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445036      PMCID: PMC124614     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Compartmentalization of subviral particles during poliovirus eclipse in HeLa cells.

Authors:  P Kronenberger; R Vrijsen; A Boeyé
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

2.  Internalization of a major group human rhinovirus does not require cytoplasmic or transmembrane domains of ICAM-1.

Authors:  D E Staunton; A Gaur; P Y Chan; T A Springer
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

3.  Identification of the integrin VLA-2 as a receptor for echovirus 1.

Authors:  J M Bergelson; M P Shepley; B M Chan; M E Hemler; R W Finberg
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

4.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.

Authors:  W M Lee; S S Monroe; R R Rueckert
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Entry of poliovirus into cells does not require a low-pH step.

Authors:  L Pérez; L Carrasco
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

7.  Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released.

Authors:  J M Casasnovas; T A Springer
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.

Authors:  H Hoover-Litty; J M Greve
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Characterization of poliovirus conformational alteration mediated by soluble cell receptors.

Authors:  A Gómez Yafal; G Kaplan; V R Racaniello; J M Hogle
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

10.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.

Authors:  T J Smith; N H Olson; R H Cheng; H Liu; E S Chase; W M Lee; D M Leippe; A G Mosser; R R Rueckert; T S Baker
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  53 in total

1.  Distinct cellular receptor interactions in poliovirus and rhinoviruses.

Authors:  L Xing; K Tjarnlund; B Lindqvist; G G Kaplan; D Feigelstock; R H Cheng; J M Casasnovas
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.

Authors:  A Reischl; M Reithmayer; G Winsauer; R Moser; I Gösler; D Blaas
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions.

Authors:  Erica Silberstein; Li Xing; Willem van de Beek; Jinhua Lu; Holland Cheng; Gerardo G Kaplan
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Receptor priming of major group human rhinoviruses for uncoating and entry at mild low-pH environments.

Authors:  Ghasem Nurani; Birgitta Lindqvist; José M Casasnovas
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

7.  Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.

Authors:  Elizabeth A Hewat; Dieter Blaas
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

8.  Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH.

Authors:  Abdul Ghafoor Khan; Johannes Pichler; Anke Rosemann; Dieter Blaas
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

9.  Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis.

Authors:  Marianne Brabec; Daniela Schober; Ernst Wagner; Nora Bayer; Robert F Murphy; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

10.  Recombinant VP4 of human rhinovirus induces permeability in model membranes.

Authors:  Matthew P Davis; Graham Bottley; Lucy P Beales; Richard A Killington; David J Rowlands; Tobias J Tuthill
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.